Possible Shift in Medicare Drug Organization May Give Pharma Heartburn - The Street
Mike Strazzella, Practice Group Leader of Buchanan's Federal Government Relations practice and head of the firm's Washington D.C. office, comments on the White House's latest proposal to reduce drug costs, and warned of its complexity, in The Street's "Possible Shift in Medicare Drug Organization May Give Pharma Heartburn."
Contributors
Related Services & Industries